COLEMAN JON (EVP, Chief Commercial Officer) sold 9.3% of their position (9.82K shares) of DEXCOM INC on the open market
Open‑market sale worth $722.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/5/2026ACC: 0001093557-26-000127
Officer· EVP, Chief Commercial Officer
Since Mar 2026
-9.82K
Net shares
Net seller
$722.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.91K
Price / share
$73.00
Trade value
$358.58K
% of position
4.7%
6/3/2026
105.27K→100.36K
Common Stock
Direct
Shares
−4.91K
Price / share
$74.13
Trade value
$364.05K
% of position
4.9%
6/4/2026
100.36K→95.45K
Total
Net shares
−9.82K
Net value
-$722.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | S · Sale | −4.91K | $73.00 | $358.58K | 4.7% | 105.27K | 100.36K |
| Common Stock Direct | 6/4/2026 | S · Sale | −4.91K | $74.13 | $364.05K | 4.9% | 100.36K | 95.45K |
| Total | −9.82K | -$722.63K | ||||||
Derivative Transactions0
No derivative transactions reported